Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Venous Thromboembolism
Open-data reference.
48 US clinical trials · 17 currently recruiting
Active & Recent Trials
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
Manuel Monreal
NCT02832245
Evaluation of the SCALED (SCaling AcceptabLE cDs)
University of Minnesota
NCT05628207
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
University of Miami
NCT04295486
Filter Initial & Long Term Evaluation After Placement and Retrieval Registry
Stanford University
NCT01158482
PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism
University of Calgary
NCT05756244
Aspiration Thrombectomy Using the Symphony or Prodigy System
Imperative Care
NCT07350499
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
Quercis Pharma
NCT06861088
Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)
Brigham and Women's Hospital
NCT03728166
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Inari Medical
NCT05701917
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
Memorial Sloan Kettering Cancer Center
NCT07399977
Warfarin Patient Self-management Implementation in the US Healthcare System
University of Utah
NCT04766216
CLEANer Aspiration for Pulmonary Embolism
Argon Medical Devices
NCT06189313
Supplemental Oxygen in Pulmonary Embolism (SO-PE)
Massachusetts General Hospital
NCT05891886
Apixaban or Enoxaparin After Head and Neck Cancer Surgery
Kiranya Arnold
NCT07189897
Venous Thromboembolism Prevention in Outpatients With Glioma
University of Vermont Medical Center
NCT05683808
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
Medical University of South Carolina
NCT06451003
Glioblastoma Remote Monitoring and Care - Research Protocol
Case Comprehensive Cancer Center
NCT06129760
An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Coagulation, and Sepsis Are Related
Bayer
NCT06765681
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
Anthos Therapeutics
NCT05171075
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use
University of Michigan
NCT05351749
A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)
Regeneron Pharmaceuticals
NCT06299111
Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study
University of California, San Francis
NCT03292666
Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered
Brigham and Women's Hospital
NCT02969343
Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims Data
Brigham and Women's Hospital
NCT04736719
Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events
Vanderbilt University Medical Center
NCT04574895
Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events
Thrombosis Research Institute
NCT02155491
Epidemiology of Venous Thromboembolism
Brigham and Women's Hospital
NCT00456196
EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization
Sanofi
NCT00077753
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
Sanofi
NCT00679588
Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy
Sanofi
NCT00694382
Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement.
Bayer
NCT00362232
The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
Medco Health Solutions
NCT00830570
Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism
Indiana University
NCT03404635
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery
Sanofi
NCT00718224
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Alliance Foundation Trials
NCT02744092
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Washington University School of Medicine
NCT00790335
LEAVE Safe With DOACs
University of Massachusetts, Worcester
NCT04068727
Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy
University of Colorado, Denver
NCT02366871
Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients
University of Utah
NCT00810784
Thrombosis Outcomes in Pediatric Venous Thromboembolism
University of Texas Southwestern Medical Center
NCT03068923
Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients
University of Utah
NCT02687204
Use of Tranexamic Acid in Reduction Mammoplasty
Montefiore Medical Center
NCT04947514
Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma
University of Utah
NCT03339349
Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study
Daiichi Sankyo
NCT02303431
The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma
Denver Health and Hospital Authority
NCT01050153
EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis
Bayer
NCT02309411
Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE)
University of Vermont
NCT01524653
Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolism
New York Medical College
NCT04041843
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 3 |
| Phase 2 | 8 |
| Phase 3 | 7 |
| Phase 4 | 3 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Venous Thromboembolism Trial Landscape
ClinicalTrials.gov lists 48 US studies indexed under Venous Thromboembolism, and 17 of those are currently open to recruitment — roughly 35% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Venous Thromboembolism shows 10 late-stage studies (Phase 3 and Phase 4 combined) alongside 11 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Venous Thromboembolism is led by Sanofi with 4 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 48 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Venous Thromboembolism?
PlainTrial tracks 48 US clinical trials for Venous Thromboembolism, of which 17 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Venous Thromboembolism?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.